TALF peptide-immunoglobulin G conjugates that bind lipopolysaccharide

Journal of Endotoxin Research

Volumn 3, Issue 1, 1996, Pages 49-55

  Fletcher, Mark A ^a,c   Kloczewiak, Marek ^b   Loiselle, Paul M ^a   Amato, Steve F ^a   Black, Kerry M ^a   Warren, H Shaw ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CURIS INC   (United States)

^c Pasteur Merieux Connaught   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; IMMUNOBLOTTING; NONHUMAN; SEPSIS;

EID: 0029865049     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300106     Document Type: Article

References (23)

1. Warren H.S., Danner R.L.; Munford R.S. Anti-endotoxin monoclonal antibodies. N Engl J Med 1992; 326: 1153-1157.
2. Warren H.S., Amato S.F., Fitting C. et al. Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 1993; 177: 89-97.
3. Rustici A, Velucchi M., Faggioni R. et al. Molecular mapping and detoxification of lipid A binding site by synthetic peptides. Science 1993; 259: 381-385.
4. Morrison D.C., Jacobs D.M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 1976; 13: 813-818.
5. Gazzano-Santoro H., Parent J.B., Grinna L. et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 1992; 60: 4754-4761.
6. Hirata M., Shimomura Y., Yoshida M. et al. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun 1994; 62: 1421-1426.
7. Larrick J.W., Hirata M, Balint R.F., Lee J., Zhong J., Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63: 1291-1297.
8. Warren H.S., Glennon M.L., Wainwright N. et al. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infect Immun 1992; 60: 2506-2513.
9. Monta T., Ohtsubo S., Nakamura T. et al. Isolation and biological activities of Limulus anticoagulant (anti-LPS factor) which interacts with lipopolysaccharide (LPS). J Biochem 1985; 97: 1611-1620.
10. Bannatyne R.M., Cheung R. Protective effect of polymyxin B sulphate in experimental enterobacterial infection in mice. Can J Microbiol 1979; 25: 995-998.
11. Corrigan Jr J.J., Bell B.M. Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulphate. J Lab Clin Med 1971; 77: 802-810.
12. Rifkind D. Prevention by polymyxin B of endotoxin lethality in mice. J Bacteriol 1967; 93: 1463-1464.
13. Animons W.S., Kohn F.R., Kung A.H.C. Protective effects of an N-terminal fragment of bactericidal/permeability increasing protein in rodent models of Gram-negative sepsis: role of bactericidal properties. J Infect Dis 1994; 170: 1473-1482.
14. Kohn F.R., Animons W.S., Horwitz A. et al. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability increasing protein in experimental endotoxemia. J Infect Dis 1993; 168: 1307-1310.
15. Vandermeer T.J., Menconi M.J., Zhuang J. et al. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs. Surgery 1995; 117: 656-662.
16. Alpert G.A., Baldwin G., Thompson C. et al. Limulus antilipopolysaccharide factor protects rabbits from meningococcocal endotoxin shock. J Infect Dis 1992; 165: 494-500.
17. Chia J.K.S., Pollack M., Guelde G., Koles N.L., Miller M., Evans M.E. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J Infect Dis 1989; 159: 872-880.
18. Warren H.S., Novitsky T.J., Bucklin A., Kania S.A., Siber G.R. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria. Infect Immun 1987; 55: 1668-1673.
19. Aketagawa J., Miyata T., Ohtsubo S. et al. Primary structure of Limulus anticoagulant anti-lipopolysaccharide factor. J Biol Chem 1986; 261: 7357-7365.
20. Hoess A., Watson S., Siber G.R., Liddington R. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Ȧ resolution. EMBO J 1993; 12: 3351-3356.
21. Kloczewiak M., Black K.M., Loiselle P., Cavaillon J-M., Wainwright N., Warren H.S. Synthetic peptides that mimic the binding site of horseshoe crab anti-lipopolysaccharide factor. J Infect Dis 1994; 170: 1490-1497.
22. Bhattacharjee A., Williams W., Siber G., Cross A. Covalent polymyxin B-starch and polymyxin B-immunoglobulin G conjugates. Clin Res 1992; 40: 237A Abstract.
23. Carlsson J., Drevin H., Axen R. Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterofunctional reagent. Biochem J 1978; 173: 723-737.